Nureca Ltd - 543264 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting15-05-2024
15-05-2024
Nureca Ltd - 543264 - Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results (Standalone And Consolidated) For The Fourth Quarter And Full Year Ended On March 31, 2024
Nureca Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2024 ,inter alia, to consider and approve the audited Financial Results (Standalone and Consolidated) for the fourth quarter and full year ended on March 31, 202408-05-2024
Nureca Ltd - 543264 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyNureca Ltd 2CIN NO.L24304MH2016PLC320868 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.40 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Chetna Anand Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Naresh Gupta Designation: Chief Financial Officer EmailId: [email protected] Date: 16/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.16-04-2024
Nureca Ltd - 543264 - Compliance Under Regulation 40(10) Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find enclosed herewith copy of Certificate, received from a Company Secretary in Practice as required under 40(9) of the Securities Exchange Board of India (Listing obligations and Disclosure Requirements) Regulations, 2015, for the year ended March 31, 2024.10-04-2024
Nureca Ltd - 543264 - Compliance Certificate - Regulation 7 (3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Please find attached Compliance Certificate-Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.09-04-2024
Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached Press Release titled " Nureca Limited''s Dr Trust Recognized as a ''Well Known Trademark'' by the Indian Trademark Registry"02-04-2024
Nureca Ltd - 543264 - Closure of Trading Window
Trading Window for dealing in the equity shares of the Company will remain closed from April 01, 2024 (Monday) till the completion of 48 hours after the declaration of audited financial results of the Company for the fourth quarter and full year ending on March 31, 202427-03-2024
Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached herewith Press Release titled " Dr Trust ranked No.1 in India''s Top Home Healthcare and Wellness Brands"01-03-2024
Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of the unaudited financial results for the third quarter and nine months ended December 31, 202308-02-2024